Laidlaw Capital Markets is Lead Manager in aTyr Pharma’s (LIFE) $86,250,000. Offering.Stephen DeLorme2021-09-16T20:29:33-04:00September 16th, 2021|Read More
Laidlaw Capital Markets is pleased to have acted as Sole Book-Runner on the $10,000,000 Follow-On Offering for BioSig Technologes (BSGM).Stephen DeLorme2021-07-12T10:07:55-04:00July 12th, 2021|Read More
How advisor platforms are changing the offshore industrydan2021-07-07T03:28:55-04:00July 7th, 2021|Read More
Laidlaw expands international business with new Miami-area officedan2021-07-07T03:24:29-04:00July 7th, 2021|Read More
Laidlaw Capital Markets is pleased to have acted as Co-Manager on the $125,000,000 Follow-On Offering for Aldeyra Therapeutics.Stephen DeLorme2021-04-30T19:38:18-04:00April 30th, 2021|Read More
Stay In Touch